Cart
sales@molnova.com
1-Methyluric acid
CAS No. 708-79-2
1-Methyluric acid( 1-Methyl-2,6,8-trihydroxypurine | 1-Methylurate )
Catalog No. M26012 CAS No. 708-79-2
1-Methyluric acid acts on the urinary bladder mucosa and increases blood glucose, triglyceride, insulin, and cholesterol levels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 378 | In Stock |
|
| 10MG | 607 | In Stock |
|
| 25MG | 940 | In Stock |
|
| 50MG | 1237 | In Stock |
|
| 100MG | 1665 | In Stock |
|
| 200MG | 2251 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Methyluric acid
-
NoteResearch use only, not for human use.
-
Brief Description1-Methyluric acid acts on the urinary bladder mucosa and increases blood glucose, triglyceride, insulin, and cholesterol levels.
-
Description1-Methyluric acid acts on the urinary bladder mucosa and increases blood glucose, triglyceride, insulin, and cholesterol levels.
-
In Vitro——
-
In VivoPerfusion of the urinary bladder with 1-Methyl uric acid solution shows an increase in the serum total cholesterol level, true triglyceride level, glucose level and insulin level on comparison with perfusion of the urinary bladder with distilled water.
-
Synonyms1-Methyl-2,6,8-trihydroxypurine | 1-Methylurate
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number708-79-2
-
Formula Weight182.139
-
Molecular FormulaC6H6N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : < 0.1 mg/mL (insoluble))
-
SMILESCn1c(=O)[nH]c2[nH]c(=O)[nH]c2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VT104
VT104 is a potent and orally active YAP/TAZ inhibitor for cancer research. VT104 blocks palmitoylation of endogenous TEAD1 and TEAD3 proteins.
-
DCLK1-IN-1
DCLK1-IN-1 is a selective and in vivo-compatible chemical probe of the DCLK1 kinase domain .
-
DL-Buthionine-(SR)-s...
DL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase?for the treatment of solid tumors.
